MedTrace Logo

NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers

NCT03666650 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-09-17

No results posted yet for this study

Summary

Relationship of edoxaban plasma concentration and blood coagulation in healthy volunteers using standard laboratory tests and viscoelastic analysis

Conditions

  • Blood Coagulation Disorder

Interventions

DRUG

Edoxaban 60 MG

Viscoelastic analysis and standard laboratory tests after edoxaban ingestion

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-26
Primary Completion
2019-01-08
Completion
2019-01-08

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03666650 on ClinicalTrials.gov